Filtros de búsqueda

Lista de obras de

44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617-preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617.

artículo científico publicado en 2017

Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile

artículo científico publicado en 2018

Alpha-PET for Prostate Cancer: Preclinical investigation using 149Tb-PSMA-617

scientific article published on 28 November 2019

Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC

artículo científico publicado en 2020

Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer Institute

scientific article published on 02 September 2019

Design and Preclinical Evaluation of an Albumin-Binding PSMA Ligand for Cu-Based PET Imaging

scientific article published on 30 October 2018

Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity

artículo científico publicado en 2020

Developments toward the Implementation of 44Sc Production at a Medical Cyclotron

artículo científico publicado en 2020

First Clinicopathologic Evidence of a Non-PSMA-Related Uptake Mechanism for 68Ga-PSMA-11 in Salivary Glands

artículo científico publicado en 2019

Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy.

artículo científico publicado en 2018

Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer

artículo científico publicado en 2019

Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.

artículo científico publicado en 2018

Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer

artículo científico publicado en 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda